Volatility of scheme returns is significantly higher than average volatility of the category

This measures the volatility of monthly returns of the scheme (in the last 3 years) with respect to average volatility of the category. Higher number implies that scheme has been riskier that average category risk

What is Volatility (3Y)?

The scheme has marginally underperformed its benchmark (NIFTY Healthcare Total Return Index.) with an alpha of -0.16% in the last 3 years

This measures the risk-adjusted outperformance of the scheme with respect to the benchmark calculated based on last 3 years of performance. Higher alpha implies higher outperformance (in the last 3 years)

What is Alpha (3Y)?

3-year CAGR of 21.56% is between 25th and 75th percentile in its category - Equity: Sectoral-Pharma

This is measured by percentile rank of the scheme in its category based on 3-year CAGR. Lower rank implies that scheme was a relative outperformer in its category

What is CAGR (3Y)?

Expense ratio of the scheme (1.51%) is roughly in line with average expense ratio of the category (1.66%), excluding index funds and ETFs

This measures the relative expense of the scheme with respect to average expense ratio of the category. Investors should always prefer schemes with lower expense, everything else remaining the same

What is Expense ratio?